Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036859 | SCV000060514 | benign | not specified | 2012-03-02 | criteria provided, single submitter | clinical testing | 442+8C>T in intron 8 of ELN: This variant is not expected to have clinical signi ficance because it has been identified in 1.4% (101/7010) of European American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs55868272). |
Prevention |
RCV000036859 | SCV000304577 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000476021 | SCV000469872 | likely benign | Supravalvar aortic stenosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000283343 | SCV000469873 | likely benign | Cutis laxa, autosomal dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000476021 | SCV000563051 | benign | Supravalvar aortic stenosis | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668155 | SCV001883222 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000036859 | SCV005203057 | benign | not specified | 2024-07-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001668155 | SCV005220359 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000036859 | SCV001809705 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000036859 | SCV001930658 | benign | not specified | no assertion criteria provided | clinical testing |